These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 27683128)

  • 21. Survival Mechanisms and Influence Factors of Circulating Tumor Cells.
    Wang WC; Zhang XF; Peng J; Li XF; Wang AL; Bie YQ; Shi LH; Lin MB; Zhang XF
    Biomed Res Int; 2018; 2018():6304701. PubMed ID: 30515411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current progress in the clinical use of circulating tumor cells as prognostic biomarkers.
    Jin KT; Chen XY; Lan HR; Wang SB; Ying XJ; Abdi SM; Wang W; Hu ZM; Mou XZ
    Cancer Cytopathol; 2019 Dec; 127(12):739-749. PubMed ID: 31589381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells.
    Liu H; Zhang X; Li J; Sun B; Qian H; Yin Z
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):189-201. PubMed ID: 24965746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
    Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
    Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Tumor Cells as Cancer Biomarkers in the Clinic.
    Chinen LTD; Abdallah EA; Braun AC; Flores BCTCP; Corassa M; Sanches SM; Fanelli MF
    Adv Exp Med Biol; 2017; 994():1-41. PubMed ID: 28560666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells.
    Werner S; Stenzl A; Pantel K; Todenhöfer T
    Adv Exp Med Biol; 2017; 994():205-228. PubMed ID: 28560676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases.
    Mamdouhi T; Twomey JD; McSweeney KM; Zhang B
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):297-305. PubMed ID: 31053984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of circulating tumor cells and disseminated tumor cells in primary breast cancer.
    Hayashi N; Yamauchi H
    Breast Cancer; 2012 Apr; 19(2):110-7. PubMed ID: 21643809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disseminated tumour cells in bone marrow are the source of cancer relapse after therapy.
    Sai B; Xiang J
    J Cell Mol Med; 2018 Dec; 22(12):5776-5786. PubMed ID: 30255991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
    Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
    Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modalities to enumerate circulating tumor cells in the bloodstream for cancer prognosis and to monitor the response to the therapy.
    Romano G
    Drugs Today (Barc); 2017 Sep; 53(9):501-514. PubMed ID: 29238763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial to mesenchymal plasticity: role in cancer progression.
    Raja R; Pandey A; Kumar P
    Front Biosci (Landmark Ed); 2020 Jan; 25(5):838-873. PubMed ID: 31585920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer.
    Ueo H; Sugimachi K; Gorges TM; Bartkowiak K; Yokobori T; Müller V; Shinden Y; Ueda M; Ueo H; Mori M; Kuwano H; Maehara Y; Ohno S; Pantel K; Mimori K
    Br J Cancer; 2015 Apr; 112(9):1519-26. PubMed ID: 25880010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-Mesenchymal Plasticity in Circulating Tumor Cells, the Precursors of Metastasis.
    Burr R; Gilles C; Thompson EW; Maheswaran S
    Adv Exp Med Biol; 2020; 1220():11-34. PubMed ID: 32304077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness.
    Caceres G; Puskas JA; Magliocco AM
    Cancer Control; 2015 Apr; 22(2):167-76. PubMed ID: 26068761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer.
    Correnti M; Raggi C
    Oncotarget; 2017 Jan; 8(4):7094-7115. PubMed ID: 27738343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response.
    Li TT; Liu H; Li FP; Hu YF; Mou TY; Lin T; Yu J; Zheng L; Li GX
    World J Gastroenterol; 2015 Dec; 21(47):13259-67. PubMed ID: 26715808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
    Mitra A; Mishra L; Li S
    Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.